Table 2.
Author | Study type (POS, ROS, RCT) |
Number of pt | Age (ye ars) |
Gender | Mean radiation dosag e (gray) |
HBO | Impl location (number of impl) |
Impl placed | Mean time interval | Impl in sit u |
Impl lost | ORN cas es |
Mean follow-up (months) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | max vs. mand | Native vs. graft | RT and impl (months) | Impl and loading (months) | |||||||||||
Brogniez et al. 1998 [88] | ROS | 19 | 53 | 16 | 3 | 57 (1 pt Ø) | 0 | max: 3, mand: 50 | Mixed | 53 | 17, post-RT | 6 | 36 | 17 | 0 | 38 |
Keller et al. 1998 [89] | ROS | 31 (total) | 50.5 | 16 | 15 | Ø | 0 | mand | Mixed | 154 | Ø | Ø | 147 | 7 | 0 | 64.2 |
19 | 41.5 | 12 | 7 | 0 | 0 | mand |
Native: 19 Graft: 72 |
91 | Ø | 7.8 | 85 | 6 | 0 | 77.5 | ||
3 | 41.3 | 1 | 2 | 0 | 0 | mand |
Native: 7 Graft: 9 |
16 | Ø | 5–6 | 16 | 0 | 0 | 28.7 | ||
4 | 65.5 | 0 | 4 | 62.1 | 0 | mand |
Native: 12 Graft: 10 |
22 | > 7, post-RT | 4–6 | 22 | 0 | 0 | 50 | ||
5 | 57 | 3 | 2 | 60.8 | 0 | mand |
Native: 7 Graft: 18 |
25 | > 13, post-RT | 4–6 | 24 | 1 | 0 | 42.2 | ||
Esser et al. 1999 [90] | ROS | 28 | 55.3 | 23 | 5 | 0 | 0 | mand | Native | 128 | Ø | 5.1 | 106 | 22 | 0 | 53.3 |
34 | 54.7 | 28 | 6 | 60 | 0 | mand | Native | 148 | 23.1, post-RT | 5.2 | 73 | 75 | 1 | 62.2 | ||
Schoen et al. 2003 [91] | ROS | 5 | 54 | 3 | 2 | 61.6 | Ø | mand | Ø | 20 | 1.5, pre-RT | 6 | 16 | 4 | 0 | 22 |
Iizuka et al. 2005 [76] | ROS | 28 (total) | 58.2 | 19 | 9 |
65: 19 pt 0: 9 pt |
0 | mand | Ø | 37 | Ø | Ø | 37 | 0 | 0 | 45 |
18 | Ø | Ø |
65: 9 pt 0: 9 pt |
0 | mand | Ø | 24 | Post-RT: 9 pt | Ø | 24 | 0 | 0 | Ø | |||
10 | Ø | Ø | 65 | 0 | mand | Ø | 13 |
Pre-RT: 7 pt Pre + post-RT: 3 pt |
Ø | 13 | 0 | 0 | Ø | |||
Shaw et al. 2005 [92] | ROS |
77 (total, 4 dropouts excluded) |
58 | 49 | 32 | Ø | 24 | Mixed |
Native: 241 Graft: 123 |
364 | Ø | 3–6 | 308 | 56 | 2 | 42 |
43 | Ø | Ø | Ø | 7 | Mixed | Ø | 192 | Ø | 3–6 | 167 | 25 | 0 | Ø | |||
34 | Ø | Ø | 50 (3 pt Ø) | 17 | Mixed | Ø | 172 | 12, post-RT | 3–6 | 141 | 31 | 2 | Ø |
HBO, hyperbaric oxygen therapy; impl, implants; mand., mandible; max, maxilla; ORN, osteoradionecrosis; POS, prospective observational study; pt, patients; RCT, randomized control study; ROS, retrospective observational study; RT, radiotherapy; Ø, unspecified